期刊文献+

扩增受阻突变体系-PCR和限制性酶切片段多态性-PCR技术在研究子宫颈癌MMP-2单核苷酸多态性中的比较

Comparison of the application of ARMS-PCR and RFLP-PCR techniques in research of single nucleotide polymorphisms about MMP-2 in cervical cancer
原文传递
导出
摘要 目的研究扩增受阻突变体系-聚合酶链反应(ARMS—PCR)和限制性酶切片段多态性-聚合酶链反应(RFLP—PCR)技术的优缺点,探讨其在单核苷酸多态性(SNP)检测及分析中的应用。方法采用ARMS—PCR和RFLP—PCR技术检测分析山西省子宫颈癌患者及健康对照组MMP-2基因启动子区域-1306C/T多态性,其结果经DNA测序验证。结果经ARMS—PCR扩增出MMP-2基因启动子CC、CT、TT三种基因型相应的DNA片段,与DNA测序结果符合。结论ARMS—PCR技术操作简便、省时、成本低,结果稳定可靠,对于一些SNP的研究具有较高的应用价值。 Objective To compare the advantages and disadvantages of the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) with restriction fragment length polymorphism- polymerase chain reaction(RFLP-PCR) technology, then explore its application in detection and analysis of single nueleotide polymorphism (SNP). Methods By using ARMS-PCR and RFLP-PCR the polymorphisms of the MMP-2 in cervical cancer and the normal-control group were analyzed. The research sites were-1306 C/T. The final result was verified by DNA sequencing. Results The results of amplified used ARMS-PCR showed that the genotypes of the SNP site in MMP-2 gene promoter were CC, CT, TT, and the DNA fragments were corresponding with the results of DNA sequencing. Conclusion ARMS-PCR technology has the advantages of lower cost time-saving simple operation and reliable results, while has a high value for research of SNP.
出处 《肿瘤研究与临床》 CAS 2009年第11期742-744,共3页 Cancer Research and Clinic
基金 山西省自然科学基金(2006011121)
关键词 子宫颈肿瘤 聚合酶链反应 多态性 单核苷酸 MMP-2 Uterine cervical neoplasms Polymerase chain reaction Polymorphism, single nucleotide MMP-2
  • 相关文献

参考文献9

  • 1Wang PH, Ko JL, Tsai HT, et al. Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array. Gynecol Oncol, 2008, 108: 533-542. 被引量:1
  • 2Tee YT, Han CP, Ko JL, et al. Evaluation of matrix metalloproteinase-2 expression in cervical carcinogenesis using tissue array and integrated optical density for immunoreactivity. Reprod Sci, 2007, 14: 719-726. 被引量:1
  • 3Yu C, Zhou Y, Miao X, et al. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res, 2004, 64: 7622-7628. 被引量:1
  • 4Zhou Y, Yu C, Miao X, et al. Functional haplotypes in the promoter of matrix mctalloproteinase-2 and lung cancer susceptibility. Carcinogenesis, 2005, 26:1117-1121. 被引量:1
  • 5Xu E, Lai M, Lv B, et al. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer. Biochem Biophys Res Commun, 2004, 324: 999-1003. 被引量:1
  • 6李秀兰,康山,赵喜娃,张晓娟,周荣秒,王娜,贾静辉,赵健,李琰.MMP-2和TIMP-2基因启动子区多态性与卵巢上皮性癌关系的研究[J].遗传,2008,30(4):455-462. 被引量:15
  • 7赵书平,张俊洁,尤建,杨玉红,郭峰.一种碘化钾提取外周血基因组DNA的方法[J].中华医学遗传学杂志,1999,16(6):395-396. 被引量:57
  • 8Ruiz-Sanz JI, Aurrekoetxea I, Ruiz del Agua A, et al. Detection of catechol-O-methyhransferase Val158Met polymorphism by a simple one-step tetra-primer amplification refractory mutation system-PCR. Mol Cell Probes, 2007, 21: 202-207. 被引量:1
  • 9Manchanda PK, Kumar A, Kaul A, et al. Correlation between a gene polymorphism of tumor necrosis factor- α (G/A) and end-stage renal disease: a pilot study from north India. Clin Chim Acta, 2006, 370: 152-157. 被引量:1

二级参考文献16

  • 1周郁,中华医学检验杂志,1993年,16卷,6期,349页 被引量:1
  • 2杨道理,DNA扩增技术与医学应用,1992年,5页 被引量:1
  • 3Price SJ,Greaves DR,Watkins H.Identification of novel,functional genetic variants in the human matrix metallo-proteinase-2 gene:role of Spl in allele-specific transcriptional regulation.J Biol Chem,2001,276(10):7549-7558. 被引量:1
  • 4De Clerck YA,Darville MI,Eeckhout Y,Rousseau GG.Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinase-2(TIMP-2).Gene,1994,139(2):185-191. 被引量:1
  • 5Zhou Y,Yu C,Miao X,Wang Y,Tan W,Sun T,Zhang X,Xiong P,Lin D.Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.Carcinogenesis,2005,26(6):1117-1121. 被引量:1
  • 6Zhou Y,Yu C,Miao X,Tan W,Liang G,Xiong P,Sun T,Lin D.Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.Carcinogenesis,2003,25(3):399-404. 被引量:1
  • 7Wu CY,Ww MS,Chen YJ,Chert CJ,Chen HP.Shun CT,Chen GH,Huang SP,Lin JT.Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer.Eur J Cancer,2007,43(4):799-808. 被引量:1
  • 8Yu C,Zhou Y,Miao X,Xiong P,Tan W,Lin D.Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.Cancer Res,2004,64(20):7622-7628. 被引量:1
  • 9Xu E,Lai M,Lv B,Xing X,Huang Q,Xia X.A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with coloreetal cancer.Biochem Biophys Res Commun,2004,324(3):999-1003. 被引量:1
  • 10Miller SA,Dybes DD,Polesky HE A simple salting out procedure for extracting DNA from human nucleated cells.Nucleic Acid Res,1988,16:1215. 被引量:1

共引文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部